T
TFX
TFXVerified7 segments tracked|6 years of data|Annual (10-K)
Total Revenue
$3.0B2.4%
FY2024
Operating Segments
7Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Vascular Access
Segment Shift
Vascular Access has grown from 23.2% to 24.0% of total revenue since FY2019, with 0.0% operating margins. Meanwhile, Interventional is the fastest growing at +14.6% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Vascular Access | $733M | $0 | 0.0% | 24.0% | +3.5% |
| Interventional | $586M | $0 | 0.0% | 19.2% | +14.6% |
| Surgical | $450M | $0 | 0.0% | 14.8% | +5.4% |
| Anesthesia | $395M | $0 | 0.0% | 13.0% | +1.4% |
| Oem | $345M | $0 | 0.0% | 11.3% | +5.7% |
| Interventional Urology | $331M | $0 | 0.0% | 10.9% | +3.5% |
| Other | $207M | $0 | 0.0% | 6.8% | -29.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free